273 related articles for article (PubMed ID: 32005973)
21. SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients.
Yu H; Sun J; Zhao C; Wang H; Liu Y; Xiong J; Chang J; Wang M; Wang W; Ye D; Zhou H; Yu T
BMC Cancer; 2019 Jul; 19(1):736. PubMed ID: 31345185
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
[TBL] [Abstract][Full Text] [Related]
23. CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression.
Wu D; He J; Zhang W; Wang K; Jin S; Li J; Gao W
Aging (Albany NY); 2020 Jun; 12(11):10578-10593. PubMed ID: 32487779
[TBL] [Abstract][Full Text] [Related]
24. Human lung cancer-derived immunosuppressive plasmacytoid dendritic cells release IL-1α in an AIM2 inflammasome-dependent manner.
Sorrentino R; Terlizzi M; Di Crescenzo VG; Popolo A; Pecoraro M; Perillo G; Galderisi A; Pinto A
Am J Pathol; 2015 Nov; 185(11):3115-24. PubMed ID: 26506473
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail.
Deng M; Liu B; Zhang Z; Chen Y; Wang Y; Wang X; Lv Q; Yang X; Hou K; Che X; Qu X; Liu Y; Zhang Y; Hu X
Cancer Sci; 2020 Sep; 111(9):3210-3221. PubMed ID: 32519357
[TBL] [Abstract][Full Text] [Related]
26. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
27. Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer.
Peng Y; Yang J; Zhang E; Sun H; Wang Q; Wang T; Su Y; Shi C
Cancer Gene Ther; 2012 Oct; 19(10):690-6. PubMed ID: 22918472
[TBL] [Abstract][Full Text] [Related]
28. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
29. CircABCB10 promotes nonsmall cell lung cancer cell proliferation and migration by regulating the miR-1252/FOXR2 axis.
Tian X; Zhang L; Jiao Y; Chen J; Shan Y; Yang W
J Cell Biochem; 2019 Mar; 120(3):3765-3772. PubMed ID: 30417418
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
He D; Wu Z; He J; Wang Y; Li Z; Gao S
Gene; 2019 May; 696():47-53. PubMed ID: 30771479
[TBL] [Abstract][Full Text] [Related]
31. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy.
Xian H; Liou YC
Autophagy; 2019 Dec; 15(12):2107-2125. PubMed ID: 30894073
[TBL] [Abstract][Full Text] [Related]
32. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p.
Lu G; Zhang Y
PLoS One; 2020; 15(2):e0229118. PubMed ID: 32092085
[TBL] [Abstract][Full Text] [Related]
34. Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma.
Zhan L; Cao H; Wang G; Lyu Y; Sun X; An J; Wu Z; Huang Q; Liu B; Xing J
Oncotarget; 2016 Oct; 7(40):65001-65011. PubMed ID: 27542250
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
[TBL] [Abstract][Full Text] [Related]
36. INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.
Zhang S; Zhou B; Wang L; Li P; Bennett BD; Snyder R; Garantziotis S; Fargo DC; Cox AD; Chen L; Hu G
Oncogene; 2017 Mar; 36(10):1430-1439. PubMed ID: 27641337
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
39. High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1.
Liu WL; Li CY; Cheng WC; Chang CY; Chen YH; Lu CY; Wang SC; Liu YR; Cheng MH; Chong IW; Liu PL
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807275
[TBL] [Abstract][Full Text] [Related]
40. XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression.
Cui T; Srivastava AK; Han C; Yang L; Zhao R; Zou N; Qu M; Duan W; Zhang X; Wang QE
Oncotarget; 2015 Apr; 6(12):10060-72. PubMed ID: 25871391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
